Chris Sale

AL East Notes: Sale, E-Rod, Red Sox, Orioles, Davis

By Mark Polishuk | August 6, 2018 at 8:39am CDT

After suffering a four-game sweep at Fenway Park, the Yankees are now 9.5 games behind the Red Sox for first place in the AL East. New York has posted only a 18-20 record over its last 38 games, and this slump has not only seemingly put the division title out of reach, but also raised some concern that a turn-around is needed just to ensure a wild card berth. As the New York Post’s Joel Sherman puts it, “the Red Sox are no longer the Rivals in 2018. The A’s and Mariners are.” The Yankees are just 2.5 games ahead of the red-hot Athletics for home field advantage in the wild card game, while Seattle (who also been struggling lately) is 2.5 games behind Oakland. It’s worth remembering, of course, that the Yankees are still 68-42 on the season and one rough series doesn’t write them off as World Series contenders, particularly since the club will eventually get key players like Aaron Judge and Gary Sanchez back from the disabled list.

Some more from around the AL East…

While Chris Sale won’t be activated from the disabled list as soon as he’s eligible, Red Sox manager Alex Cora told reporters (including the Boston Herald’s Jason Mastrodonato) that the delay isn’t due to any setback with Sale’s shoulder. The team was simply lining up its rotation so that Sale wouldn’t be starting, and thus batting, during an interleague series in Philadelphia next week. The ace left-hander will likely make his return to start against the Orioles on August 11 or 12, Cora said.
In other Red Sox health news, Eduardo Rodriguez threw 30 pitches off a mound on Sunday and came away “feeling good,” he told reporters (including Peter Abraham of the Boston Globe). While it isn’t yet certain what the next step in the left-hander’s recovery process will be, or even if Rodriguez will be able to return before August is through, Sunday’s throwing session was a good sign given that Rodriguez looked to have suffered a particularly severe ankle sprain back in mid-July. Rodriguez hopes to come back as a starter but is open to pitching out of the bullpen; Abraham notes that returning as a reliever would likely mean a shorter rehab process. One would think that Rodriguez (3.44 ERA, 9.5 K/9, 3.44 K/BB over 104 2/3 IP) has pitched well enough that the Sox would want him back in the rotation, but with Nathan Eovaldi now in the fold, Rodriguez may have more value in a Boston bullpen that currently lacks any left-handers.
With the Orioles now in full rebuild mode, MASNsports.com’s Roch Kubatko looks ahead to what the team might have in store for the offseason. The O’s could quite possibly continue to move veterans such as Mark Trumbo or Tim Beckham if any trade partners could be found, or potentially keep a familiar face around to serve as an experienced clubhouse voice on what is shaping up to be a much younger roster in 2019.
It also remains to be seen if the Rule 5 Draft will continue to be a significant part of the Orioles’ offseason strategy. The O’s have put a notable focus on acquiring young talent via the Rule 5 Draft in recent years, including selecting three players last winter. One player the O’s considered but didn’t select last winter was left-hander Austin Davis, Kubatko reports. Davis has since made his MLB debut and posted some strong results (3.38 ERA, 4.33 K/BB rate, 26 strikeouts in 21 1/3 IP) out of the Phillies’ bullpen this season. Given that the Orioles and Phillies were heavily involved in trade talks for such players as Manny Machado and Adam Jones in the lead-up to the July 31 deadline, it’s fair to wonder if Baltimore again tried to acquire Davis as part of negotiations.

Injury Updates: Springer, Altuve, Sale, Devers, Erasmo

By Mark Polishuk | August 5, 2018 at 6:54pm CDT

The latest on some injury situations from around baseball…

George Springer left today’s game in the third inning with what the Astros described as “left thumb discomfort.” Springer suffered the injury while sliding into second base on an attempted steal, with manger A.J. Hinch telling MLB.com’s Brian McTaggart (Twitter video link) and other reporters that Springer’s thumb was clipped by the glove of Dodgers shortstop Chris Taylor during the tag. The severity of the problem isn’t yet known, though McTaggart tweets that Springer’s x-rays were negative. Jake Marisnick took Springer’s spot in the lineup, and one would think Marisnick or youngsters Kyle Tucker or Derek Fisher would get the bulk of playing time if Springer had to miss significant time. Losing Springer would be another blow to a Houston team that has suddenly been bit by the injury bug, as such key figures as Lance McCullers Jr., Chris Devenski, and (most of all) Jose Altuve have all been placed on the DL within the last two weeks.
Speaking of Altuve, he won’t return from the disabled list after the 10-day minimum, as he’ll instead head to Houston to have his right knee re-examined by team doctors (the Houston Chronicle’s Chandler Rome was among those who reported the news). The star second baseman hit the DL on July 28, with a backdated placement of July 26, due to knee soreness. “I don’t know that we can consider it a setback other than we can consider that he needs more time to heal,” A.J. Hinch said, while GM Jeff Luhnow said the team saw the re-examination as a “checkpoint on where [Altuve is] at.” The absolute earliest Altuve could return is on Thursday for the start of the Astros’ series with the Mariners.
Chris Sale will also spend some extra time on the DL, as the Red Sox ace wasn’t listed as a probable starter during Boston’s three-game series in Toronto from Tuesday to Thursday. (MassLive.com’s Christopher Smith was among those with the information.) Mild shoulder inflammation sent Sale to the DL on July 31 (retroactive to July 28), and the expectation was that Sale would only miss one start, with a return targeted for Wednesday’s game. Instead, Brian Johnson will take the hill for the Sox against the Blue Jays.
The Red Sox could get third baseman Rafael Devers back for that Wednesday game, as the Boston Herald’s Jason Mastrodonato tweets that Devers will rejoin the team in Toronto after playing in a minor league rehab game on Monday. A hamstring strain sent Devers to the DL on July 28, and Wednesday is the first day he is eligible to return. Devers also missed some time earlier this month with shoulder inflammation. The young slugger has been inconsistent (.245/.295/.425 in 396 PA) over his first full Major League season, and his particular struggles against left-handed pitching could put Devers in platoon duty down the stretch rather than an everyday role at third base.
Erasmo Ramirez is slated for a rehab outing today and is expected to rejoin the Mariners sometime this week, the Seattle Times’ Ryan Divish writes. Ramirez has been sidelined since April recovering from a teres major strain, and has only made two appearances this season after another DL stint (lat strain) to begin the 2018 campaign. It isn’t yet clear if Ramirez will work as a starter or reliever when he is activated, as his role could hinge on whether the struggling Felix Hernandez can get on track.

Red Sox Place Chris Sale On DL

By Connor Byrne | July 31, 2018 at 4:41pm CDT

The Red Sox announced that they’ve placed left-hander Chris Sale on the disabled list, retroactive to July 28, with mild inflammation in his pitching shoulder. The team recalled righty Brandon Workman from Triple-A Pawtucket to take Sale’s roster spot.

Fortunately for Boston, expectations are that Sale will only miss one start, Pete Abraham of the Boston Globe tweets. Assuming that proves true, this won’t be a catastrophic occurrence for Boston, which has seen Sale continue to serve as an elite starter since acquiring him from the White Sox entering 2017.

Dating back to his change in Sox, Sale has worked to a tremendous 2.56 ERA/2.31 FIP with awe-inspiring strikeout and walk rates (13.04 K/9, 1.92 BB/9) across 355 1/3 innings. Last season was the third straight 200-plus-inning campaign for Sale, who has logged a 2.04 ERA/2.08 FIP with 13.21 K/9 and 2.11 BB/9 over 141 frames this year to once again put himself in Cy Young contention. Thanks in part to the 28-year-old Sale’s brilliance, Boston has registered the majors’ best record (75-33) en route to a six-game lead in the AL East.

Whether he misses one start or more, Sale will count as the third BoSox starter on the DL, joining Eduardo Rodriguez and Steven Wright – each of whom are seemingly dealing with more severe injuries. For now, the Red Sox will continue with Rick Porcello, David Price, the just-acquired Nathan Eovaldi and Drew Pomeranz in their rotation, and they’ll utilize lefty Brian Johnson as a starter to cover for Sale’s absence. However, in the event Sale’s injury proves more serious than expected (and if Rodriguez and Wright still aren’t back), perhaps Boston will end up on the lookout for yet another trade pickup prior to the end-of-August waiver deadline.

All-Star Notes: Red Sox, Lowrie, Markakis, Abreu

By Jeff Todd | July 17, 2018 at 3:10pm CDT

While the focus this time of year is obviously on trade possibilities, the All-Star break also provides reporters an opportunity to ask players about their own long-term preferences. It’s not surprising, then, that we’ve seen a run of stories on players who won’t be traded away, but also aren’t under long-term control.

The Red Sox have certainly enjoyed an excellent opening run, led by excellent performances from a number of core players. It’d be a surprise to see any mid-season dealmaking, but the club might be expected to look into some new arrangements in the offseason to come. Closer Craig Kimbrel represents the most pressing situation, since he’ll be a free agent. As Christopher Smith of MassLive.com reports, Kimbrel says he and his family would “love to stay” but certainly indicated he’ll wait to see what the market bears. Though he only arrived a few months ago, slugger J.D. Martinez says he’d be open to exploring a new pact that might eliminate some of his opt-out opportunities, as he tells Chris Cotillo of MassLive.com. Of course, there’s plenty of time left before he’s scheduled to have a shot at returning to the open market (post-2019), and there’s reason to wonder whether the organization really would want to pay up to enhance its control rights. In between those two players in terms of contract situation is staff ace Chris Sale. Nick Cafardo of the Boston Globe argues that, with one more option year left to go, the Boston organization ought to look into locking up the 29-year-old for the foreseeable future.
It seemed at one time that infielder Jed Lowrie would feature as a trade chip, but the surging Athletics obviously now have no plans to sell. Instead, attention has turned to the question whether he might end up returning to Oakland at season’s end. As John Shea of the San Francisco Chronicle writes, Lowrie says the front office has “expressed interest this time” around — unlike the prior time his contract with the A’s was nearing an end. Lowrie, a first-time All-Star in his 11th MLB season, indicated that he’d be open to working something out to return for a sixth campaign in Oakland, though it’s not clear whether any effort at mid-season talks will be made.
It’s a similar story for Braves outfielder Nick Markakis, another respected veteran who finally earned an All-Star nod. As Gabriel Burns of the Atlanta Journal-Constitution writes, Markakis indicated he expects to keep playing after his contract runs out this fall — which is no surprise given his strong performance thus far. Whether that’ll take place in Atlanta or elsewhere, though, isn’t yet on his mind. “We’ll deal with that stuff in the offseason when the time comes,” says the veteran.
Those sorts of questions have long floated around White Sox first baseman Jose Abreu, who stands out as a quality veteran on a very youthful roster. As Steve Greenberg of the Chicago Sun-Times reports, Abreu says he hopes to have a chance to win before his time is up in Chicago. His focus is on “just trying to enjoy the moment with the team” at the moment, but the slugger also indicated that he’s at least open to spending more time on the South Side. “I’d like to stay with this team,” says Abreu. “And I’m going to do all in my power to make this team good as soon as possible.”

Injury Notes: Sale, Pomeranz, Rodriguez, Gregerson, Lincecum, Hughes

By Kyle Downing | March 24, 2018 at 4:03pm CDT

Red Sox starter Chris Sale left today’s start after being struck by a comebacker off the bat of J.D. Davis. Chad Jennings of the Boston Herald was first to tweet that the club called it a hip contusion. Thankfully for fans in Boston, the X-rays on his hip came back negative (according to Pete Abraham of the Boston Globe). For his part, Sale himself has said that he feels fine and that it “looked a lot worse than it actually is.” The lack of serious injury to their prized left-hander brings a sigh of relief to the Red Sox, as they need him now more than ever; Alex Cora announced today that both Eduardo Rodriguez and Drew Pomeranz will begin the season on the DL (h/t Sean McAdams of the Boston Sports Journal). With Steven Wright set to face a 15-game suspension, that leaves Brian Johnson and Hector Velazquez at the back end of the club’s rotation. With David Price no sure bet to stay healthy, any questions surrounding Sale would have been wildly unsettling for a club hoping to compete with a tough Yankees ballclub for the AL East crown.

Other injury-related news from around the league…

Luke Gregerson, who was projected to be the Cardinals’ closer on opening day, will instead begin the season on the DL. Ben Frederickson of the St. Louis Post-Dispatch outlines the news, which comes as a result of a hamstring strain. The usually-durable Gregerson had also dealt with an oblique injury earlier in the spring, and it’s unclear when he’ll be able to return to major-league action. According to Jon Morosi of MLB.com, the club has said that Dominic Leone or Tyler Lyons will receive closing opportunities. They do not appear close to any sort of deal with free agent closer Greg Holland at this time, Morosi adds.
Speaking of right-handers who’ll begin the season on the DL, Tim Lincecum’s blister issues will put him in that company as well. Lincecum joined the Rangers on a one-year deal with a $1MM base salary just weeks ago and didn’t pitch competitively in 2017; by his own words, he was unlikely to be ready for opening day anyway. Still, the blister issue will delay The Freak’s comeback bid, which will be an interesting story to watch as the season progresses considering how much he impressed scouts in a February showcase. Lincecum’s last MLB stint was with the Angels in 2016, when he posted a 9.16 ERA across 38 1/3 innings (nine starts).
Twins right-hander Phil Hughes has a mild oblique strain, according to a tweet from Mike Berardino of the Pioneer Press. Berardino adds that a DL stint would give him more time to build up arm strength following surgery, though I’d add that Hughes might simply be utilized in a long relief role anyway. For the time being, the Twins will continue to evaluate Hughes.

East Notes: Mets, Wright, Colon, Jays, Red Sox, Sale

By Connor Byrne | January 20, 2018 at 7:09pm CDT

Injuries to his neck, spine, shoulder and back have limited Mets third baseman David Wright to 75 games since the start of 2015, derailing a potential Hall of Fame career. Now, having not played in a game since May 2016 and having undergone back surgery in October, Wright realizes the Mets can’t count on him heading into the new season. “It really hurts to say this, but I obviously can’t be relied on to go out there and do what I’ve done throughout my career,” the 35-year-old told Anthony DiComo of MLB.com. “That is a tough thing to say.” Wright added that he hasn’t made enough progress since his latest surgery to know if his back is going to hold up in 2018, though he expects to find out “closer to spring.” Unfortunately, Wright’s injuries have made the eight-year, $138MM extension he signed in 2012 a poor investment for the Mets. He’s still in line to collect $47MM over the next three years.

More from New York and two other East Coast cities:

The Blue Jays have addressed their position player group in recent weeks with the additions of Randal Grichuk, Curtis Granderson, Yangervis Solarte and Aledmys Diaz. The club still has around $10MM left to spend, and it’s primarily focused on finding a fifth starter and bolstering its bullpen, per Gregor Chisholm of MLB.com. The Jays also “remain in the mix for backup catching depth,” Ben Nicholson-Smith of Sportsnet writes. For now, Joe Biagini is penciled in as Toronto’s No. 5 starter behind Marcus Stroman, Aaron Sanchez, J.A. Happ and Marco Estrada. Biagini has spent the majority of his two-year career in the bullpen, however, and could shift back there in the event of an outside acquisition. In doing so, he’d presumably help a unit that lost reliever Dominic Leone in the Grichuk trade.
The Mets have shown offseason interest in free agent right-hander Bartolo Colon, former Twins teammate Ervin Santana told Mike Berardino of the Pioneer Press. “He just wants to win six more games and then he will retire,” Santana said of the soon-to-be 45-year-old Colon, who’s six victories away from passing Dennis Martinez’s 245 and becoming the winningest Latin American-born pitcher ever. Colon spent 2014-16 as a Met, with whom he was a reliable fan favorite. After a subpar 2017 divided between Atlanta and Minnesota, Colon was reportedly willing to consider a minor league deal to rejoin the Mets earlier this offseason, though indications were that they weren’t all that interested.
Red Sox left-hander Chris Sale wasn’t as effective in the second half of last season as he was during the first, which has led to a change in routine this winter for the 28-year-old ace, as he explained to Jason Mastrodonato of the Boston Herald. “I’ve made a couple tweaks to my throwing this year,” Sale said. “Started a bit later trying to ease into it a little more. In terms of working out, started working out earlier, doing pilates. The same things I’ve been doing conditioning and strength wise, just kind of dialing back my throwing program.” Manager Alex Cora, pitching coach Dana LeVangie and the Red Sox trainers are all on board with the changes, per Sale, who insists it won’t mean a lighter workload in 2018. Rather, after leading the American League with 214 1/3 innings last season, he expects to be similarly durable this year.

Red Sox Exercise Options On Chris Sale, Craig Kimbrel

By Steve Adams | November 2, 2017 at 10:11am CDT

The Red Sox announced this morning that they’ve formally exercised their 2018 club options over ace Chris Sale and closer Craig Kimbrel. Sale will earn $12.5MM in 2018, while Kimbrel will be paid $13MM.

Additionally, the Sox announced that they’ve outrighted left-hander Robbie Ross Jr. and infielder Josh Rutledge, each of who has elected free agency. Boston has also selected the contracts of outfielder Bryce Brentz and left-hander Williams Jerez from Triple-A Pawtucket.

The option decisions on Sale and Kimbrel were among the easiest in all of baseball. The pair finished out the season as two of the most valuable players on the Red Sox and two of the best in all of baseball in their respective roles. Sale led the American League with 214 1/3 innings and a remarkable 308 strikeouts (12.9 K/9), pitching to a stellar 2.90 earned run average along the way. Kimbrel, meanwhile, posted a 1.43 ERA with 35 saves in 69 innings and struck out a staggering 49.6 percent of the batters he faced (16.4 K/9). Sale’s contract includes a $13MM option for the 2019 season as well, while Kimbrel will be a free agent for the first time next winter.

Ross, 28, was limited to just 15 innings between the Majors and Triple-A this season due to a back injury that ultimately required surgical repair. Prior to that, however, he was a quality setup man in Boston, pitching to a 3.57 ERA with 8.5 K/9, 3.3 BB/9 and a 49.4 percent ground-ball rate in 116 innings in 2015-16. Lefties hit just .200/.302/.297 against Ross in that time, while righties hit him at a .260/.333/.388 clip. Ross would’ve been eligible for arbitration this offseason after earning $1.825MM in 2017. He’s expected to be healthy for Spring Training and could make for an affordable and experienced option for a team seeking left-handed bullpen help.

Rutledge, also 28, logged 118 plate appearances in 2017 — his third year with Boston. He’s seen very limited action with the Sox dating back to 2015, though, hitting just .252/.319/.313 in 259 plate appearances across those three seasons. The versatile Rutledge can handle second base, third base and shortstop, and he even saw 13 innings at first base for the Sox in 2017. He’ll likely land a minor league pact somewhere this offseason and compete for a bench role in Spring Training.

AL Notes: Sale, Hardy, Orioles, Twins

By Connor Byrne | August 10, 2017 at 9:14pm CDT

It’s possible the Red Sox will open contract extension talks with superstar left-hander Chris Sale during the upcoming offseason, writes Nick Cafardo of the Boston Globe. Sale has two more option years remaining at a combined $26MM, which is an absolute bargain relative to his production, but Cafardo wonders if the Red Sox should give the 28-year-old a raise in an act of good faith. While Sale certainly belongs in the elite tier of pitchers in terms of salary, the Red Sox may be reluctant to hand out a second David Price-type blockbuster deal that takes a pitcher through his 30s, Cafardo suggests. Ultimately, the Sox may choose to wait another year and then override the 2019 option with an extension if Sale is his typical self next season, notes Cafardo.

2018 Vesting Options Update

By Jeff Todd | June 28, 2017 at 10:48am CDT

We already took a preliminary look at the vesting option scenarios playing out around the game, but we’ve now gained quite a bit of clarity over the last six weeks. Generally, vesting options are club options that can become guaranteed based on the player’s health and/or performance. Typically, achieving contractually defined thresholds (such as for plate appearances or games finished) takes the decision out of the team’s hand, with some clauses also requiring certain health standards to be triggered.

Here’s where things stand at present:

Already Vested

Greg Holland: That was fast! Holland has already racked up thirty games finished, meaning that what was a $10MM mutual option for 2018 has been converted into a $15MM player option. With a league-leading 25 saves in the bank, along with 29 1/3 innings of 1.53 ERA pitching, it seems unlikely that Holland will take that cash rather than testing the open market — though he could also have to turn down a qualifying offer and hit free agency weighed down a bit by draft compensation. (Notably, too, Holland is cracking into some hefty contract incentives. He is on track to earn most or all of the $11MM in available bonus money.)

On Track To Vest

Gio Gonzalez: While Gonzalez is pitching well enough to make it a foregone conclusion that the Nationals would pick up his 2018 option at $12MM, that step won’t be necessary if he ends the regular season with 180 innings on his ledger. Working deep into games has been an issue for Gonzalez in recent years, but he has already topped 100 frames through just 16 starts thus far in 2017. Barring an injury, this one looks quite likely to vest.

Unlikely To Vest

Ricky Nolasco: The 34-year-old faces an uphill battle, but he’s at least keeping it interesting. Nolasco can turn a $13MM club option ($1MM buyout) into a player option if he gives the Halos 202 1/3 frames this year. That’s a big number, but Nolasco has managed to log 90 2/3 innings through 16 outings, leaving 111 2/3 left to achieve. Even if he takes the ball another 16 times the rest of the way, he’d need to go seven innings per start — a pace typically achievable only by a few top aces around the game. (Currently, Max Scherzer and Chris Sale top the leaderboard with 113 2/3 frames.)
Matt Cain: The Giants are sure to pay Cain a $7.5MM buyout rather than picking up his $21.5MM option for the 2018 campaign. But the veteran righty could take that decision out of the team’s hands if he’s able to reach 200 innings this year and stay off of the DL at season’s end. Cain has made all 16 of his starts so far, but he has accumulated only 84 innings. While it’s a theoretical possibility, then, it’s all but certain that this option won’t vest — and the Giants have every incentive to see that it doesn’t.
Hisashi Iwakuma: When the season started, it seemed reasonably likely that Iwakuma would trigger his second vesting season — as he did last year with the first. After compiling 199 innings in 2016, he needed to accumulate only 125 more (and avoid an unspecified injury) to lock up a $15MM payday. But Iwakuma is currently parked on the DL with just 31 frames in the bank; even if he is able to work deep in most of his remaining starts, he almost certainly won’t have enough to accumulate the 94 additional innings he needs. If he doesn’t get there, then Seattle will decide between a $10MM salary and a $1MM buyout.

Will Not Vest

Andre Ethier: Ethier’s $17.5MM club option vests upon 550 plate appearances in 2017. He has been shelved for the entire first half of the season, so he’ll have to take home a $2.5MM buyout as a consolation prize.
Matt Garza: This one is complicated, but here’s the bottom line: Garza cannot possible make enough starts to reach 110 in total from 2014-17 (he’s currently at 82), so his option cannot vest at $13MM. At the same time, it’s no longer possible for him to miss 130 or more days of action to the DL this year, so the club won’t get a shot at a $1MM option for his 2018 rights. Instead, the deal reverts to a club option at $5MM. See? It’s simple.
J.J. Hardy: The extension that Hardy signed with the O’s a few years back includes a $14MM club option (or a $2MM buyout), but that would vest if Hardy ended the 2017 campaign with 600 plate appearances on his stat sheet. That always seemed a stretch, but with his recent DL placement it’s no longer even possible.

West Notes: D-Backs, Simmons, Wolters, Toles

By Steve Adams | March 11, 2017 at 5:17pm CDT

Former Diamondbacks executive and interim general manager Jerry Dipoto (now the GM of the Mariners) tells Nick Piecoro of the Arizona Republic that the biggest regrets of his tenure in Arizona are missed opportunities in the draft. “The (mistakes) that really gnaw at me and I still wake up thinking about are the ones in the draft,” says Dipoto. “Where you had a scout or multiple scouts in the room telling you, ‘This is the guy.’ You know, ‘We should take Chris Sale.’ We should have.” Of course, the D-backs were hardly alone in passing on Sale, who fell to 13th in the first round of the 2010 draft. Still, the D-backs’ selection of Texas A&M righty Barret Loux, who ultimately didn’t even sign due to medical reasons, stings Dipoto as a misstep to this day. Dipoto adds that he hopes he’s grown as an executive from his ealier days, when he’d “run renegade on a group” of scouts or let his voice “overwhelm the opinion of the group.”

More from the game’s Western divisions…

Mariners righty Shae Simmons exited today’s Cactus League game with the trainer, tweets MLB.com’s Greg Johns. While there’s no word on the specifics of the injury just yet, that’s a troubling scene for the newly acquired flame-thrower, who has already seen one season of his career wiped out due to Tommy John surgery. Simmons is competing for one of the final spots in the Seattle ’pen and, prior to 2015 Tommy John surgery, flashed quite a bit of potential in the Atlanta relief corps. The 2014 season saw Simmons rattle off 21 2/3 innings of 2.91 ERA ball with a 23-to-11 K/BB ratio.
The Rockies have been without catcher Tony Wolters since March 5 due to a hyperextended right elbow that he suffered on a swing, but he could return to the field on either Sunday or Monday, tweets MLB.com’s Thomas Harding. The 24-year-old Wolters hit .259/.327/.395 in 230 plate appearances as a rookie last season and drew excellent marks for his pitch-framing skills. He’s expected to split time behind the dish with fellow youngster Tom Murphy in 2017 as half of the Rockies’ primary catching tandem.
Dodgers outfielder Andrew Toles tells J.P. Hoornstra of the Southern California News Group that while he knew little to nothing of sabermetrics a year ago, his newfound fascination with modern metrics aided him in his rise to the Majors last season. Toles began teaching himself the new concepts on Fangraphs and admits that they changed the way he evaluated himself. “I think that’s it,” the 24-year-old said. “You don’t look at batting average, home runs, all that.” Toles cited director of player development Gabe Kapler and the Dodgers’ general willingness to break down exactly what they’re looking for as driving factors behind his embracing of advanced metrics and said that ultimately, the advice he received paid off. “I just pretty much did what they told me to do. I listened.”

« Previous Page

Load More Posts

Show all

Headlines

Chris Sale

Navigation

MLBTR INFO

Connect